Given thatRIT1-related Noonan syndrome is caused by a gain of function in the RAS/RAF/mitogen-activated protein kinase signaling pathway, the mitogen-activated protein kinase inhibitor might be more effective than the mTOR inhibitor in such patients.6, 7. The gene discussed is WNK2; the disease is Noonan syndrome.